Ligand Pharmaceuticals, Inc. (LGND)
234.33
-1.00
(-0.42%)
USD |
NASDAQ |
May 27, 15:00
Ligand Pharmaceuticals Free Cash Flow : 114.06M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| XOMA Royalty Corp. | -14.09M |
| Johnson & Johnson | 17.80B |
| Organon & Co. | 708.00M |
| Merck & Co., Inc. | 14.12B |
| Phathom Pharmaceuticals, Inc. | -97.76M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 48.69M |
| Cash from Investing (Quarterly) | -94.35M |
| Cash from Financing (Quarterly) | -14.13M |
| Free Cash Flow Per Share (Quarterly) | 2.437 |
| Free Cash Flow to Equity (Quarterly) | 47.98M |
| Free Cash Flow to Firm (Quarterly) | 49.42M |
| Free Cash Flow Yield | 2.39% |